First Niagara Bank’s AstraZeneca AZN Stock Holding History

First Niagara Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$314K	Buy	+5,200	New	+$302K	0.09%	149
2015 Q3	–	Sell	-3,333	Closed	-$212K	–	217
2015 Q2	$212K	Buy	+3,333	New	+$228K	0.05%	224

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Niagara Bank's AZN Position: Q2 2016 in Review

First Niagara Bank opened a new position in AstraZeneca (AZN) in Q2 2016: 5,200 shares worth $314K. The stake represents 0.09% of the portfolio and ranks #149 among its holdings. This is a return to the name: First Niagara Bank previously reported a position in AZN as recently as Q2 2015.

First Niagara Bank first reported a position in AZN in Q2 2015 and has held it in 2 quarters since. 398 funds tracked by Wall St. Rank hold AZN as of Q2 2016.

First Niagara Bank held 5,200 shares of AstraZeneca worth $314K as of Q2 2016.
AstraZeneca was a new First Niagara Bank position in Q2 2016.
AstraZeneca made up 0.09% of First Niagara Bank's portfolio in Q2 2016, its #149 holding.
First Niagara Bank first reported a position in AstraZeneca in Q2 2015 and has held it in 2 quarters since.
398 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2016.

Based on First Niagara Bank's 13F filing for Q2 2016, filed 25 Jul 2016.